mavodelpar (REN001)

mavodelpar · Reneo Pharma Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for mavodelpar (REN001), covering 2024-04-03 to 2024-04-03. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of 24 Week Treatment With Mavodelpar (REN001) in Primary Mitochondrial Myopathy Patients [Phase 2]

See pricing